Executive Leadership Team
Rooted in science and technology, we are building our team from the ground up to be interdisciplinary at the core.
Ali Ansary, MD
CEO & CoFounder
Greg Finak, PhD
CTO & CoFounder
Greg is a recognized leader and pioneer in the field of computational cytometry and single-cell methods development. He is passionate about technology and opinionated about rigorous, high quality, reproducible and open science. He founded Ozette in 2020 with the guiding principle that scientific questions should push technology development. Prior to founding Ozette he served as a senior scientist at the Fred Hutchinson Cancer Research Center where he contributed to methods development and analysis of vaccine clinical trail data across HIV, TB, Malaria, and other disease areas. He graduated with a PhD from McGill. When away from the office you can find him tramping through the mountains and swinging a fly rod.
Evan Greene, PhD
VP of Quantitative Methods & Co-Founder
Raphael Gottardo, PhD
Scientific Advisor & Co-Founder
VP Product & Design
Calvin has carried a passion for good products through 20 years of invention across a wide diversity of domains. Prior to Ozette, Calvin spent more than a decade at Amazon as Head of Design leading product, design, and research for numerous teams including Alexa, New Delivery Experiences, International Expansion, and Just Walk Out/Go. Calvin focused on new product development and led teams through numerous V1 product launches including Amazon Key, Amazon Go, Amazon India, and Hub. Calvin served as Director of Software for The Broadlane Group, the healthcare spend optimization firm later acquired by MedAssets, where he focused on the digital transformation of the product portfolio. In 2003 he co-founded and launched FetchFood, an early internet restaurant delivery service. Calvin holds a BA in Cognitive Science from U.C. Berkeley.
VP Translational Science
Corrie Ortega, PhD
VP Operations & Product Strategy
Bill Glauser, PhD
Charlotte Hubbard, PhD
Sr Director, Nanostring
Dr. Charlotte Hubbert is Senior Director, Business Development & Strategic Alliances at NanoString and Strategic Director at Madrona Venture Group. Charlotte was previously Partner and head of Gates Foundation Venture Capital and Vice President at H.I.G. BioVentures. Charlotte career began in early stage biotech, investing at Accelerator Corporation. Charlotte holds a B.S. in microbiology from the University of Washington and a Ph.D from Duke University. She has been honored as a Fierce Woman in Biopharma 2016 by Fierce Pharma, and as a leading Woman in Life Sciences 2016 by Life Science Washington.